Melanoma Clinical Trials in Dallas

Showing 221-240 of 268 trials

Study to Compare the Effect of Ipilimumab Retreatment With That of Chemotherapy in Advanced Melanoma

NCT01709162

The purpose of the study is to determine whether additional doses of ipilimumab have a positive effect on survival in the treatment of advanced melanoma that has progressed after successful initial treatment with ipilimumab.

Melanoma

Bristol-Myers Squibb31 participantsStarted Mar 2013

Birmingham, Alabama, United States • Aurora, Colorado, United States • Indianapolis, Indiana, United States +14 more locations

COMPLETEDPhase 2< 1 mile

A Study of IMC-1121B (Ramucirumab) With or Without Dacarbazine in Metastatic Malignant Melanoma

NCT00533702

The primary objective of this study is to determine the progression-free survival (PFS) of participants with previously untreated metastatic malignant melanoma when treated with IMC-1121B (ramucirumab) alone or in combination with dacarbazine.

Metastatic Malignant Melanoma

Eli Lilly and Company106 participantsStarted Nov 2007

Decatur, Alabama, United States • Scottsdale, Arizona, United States • Scottsdale, Arizona, United States +14 more locations

Study to Compare the Effect of Ipilimumab Retreatment With That of Chemotherapy in Advanced Melanoma

A Study of IMC-1121B (Ramucirumab) With or Without Dacarbazine in Metastatic Malignant Melanoma

Melanoma Trials in Other Cities

Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma

Vaccine Therapy in Treating Patients With Malignant Melanoma

Comparison Study of Dendritic Cell Vaccine With and Without Cyclophosphamide to Treat Stage IV Melanoma Patients

Carboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Phase II, 2nd Line Melanoma - RAND Monotherapy

A Treatment Combination for Patients With Unresectable Stage III or Stage IV Melanoma

Study of an Oral Cdk Inhibitor Administered With an Oral BRAF Inhibitor in Patients With Advanced or Inoperable Malignant Melanoma With BRAF Mutation

STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma

Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma

Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma

Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma

Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma

Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma

MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.

SciBase International Melanoma Pivotal Study

Comparison of Ipilimumab Manufactured by 2 Different Processes in Participants With Advanced Melanoma

A Phase I/II Study of Dasatinib and Dacarbazine

Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Other Conditions in Dallas